Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ghisallo Capital Management is a hedge fund and investment management firm founded in March 2020 by Michael Germino. The firm employs a multidisciplinary approach to investing, including strategies such as multi-asset global macro, long/short equities, credit, distressed credit, event-driven and special situations investing. It manages discretionary assets totaling approximately $2.8 billion as of March 2024 and serves institutional clients[5][9]. While it invests across various industries—including healthcare—it does not itself operate in the life sciences or biotech sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ghisallo Capital Management.